Maxele Advisors LLC bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 5,271 shares of the company’s stock, valued at approximately $677,000. Merck KGaA accounts for about 0.5% of Maxele Advisors LLC’s investment portfolio, making the stock its 29th largest holding.
Several other hedge funds have also modified their holdings of MKGAF. Bank of America Corp DE acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $3,923,774,000. Legal & General Group Plc acquired a new stake in Merck KGaA during the 2nd quarter worth about $2,425,225,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in Merck KGaA during the 2nd quarter worth about $942,087,000. Caisse de depot et placement du Quebec purchased a new stake in Merck KGaA during the second quarter valued at about $571,582,000. Finally, Canada Pension Plan Investment Board purchased a new stake in Merck KGaA during the second quarter valued at about $536,694,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Stock Performance
Shares of MKGAF opened at $158.15 on Friday. The company has a 50-day moving average of $163.21 and a two-hundred day moving average of $148.95. The stock has a market cap of $20.44 billion, a price-to-earnings ratio of 24.14 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a one year low of $116.68 and a one year high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
